2,363
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Short stature in small-for-gestational-age offspring born to mothers with hypertensive disorders of pregnancy

, , , , , , , , & show all
Article: 2187623 | Received 10 Mar 2022, Accepted 01 Mar 2023, Published online: 08 Mar 2023

References

  • Iwama N, Ishikuro M, Tanaka K, et al. Epidemiological studies regarding hypertensive disorders of pregnancy: a review. J Obstet Gynaecol Res. 2020; 46(9):1672–7. DOI:10.1111/jog.14383
  • Roberts JM. Preeclampsia: what we know and what we do not know. Semin Perinatol. 2000; 24(1):24–28.
  • Staff AC. The two-stage placental model of preeclampsia: an update. J Reprod Immunol. 2019; 134-135:1–10.
  • Seki H. Balance of antiangiogenic and angiogenic factors in the context of the etiology of preeclampsia. Acta Obstet Gynecol Scand. 2014; 93(10):959–964.
  • Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: the “chicken-and-egg” question. Endocrinology. 2004; 145(11):4835–4837.
  • Gilbert JS, Gilbert SA, Arany M, et al. Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension. 2009; 53(2):399–403. DOI:10.1161/HYPERTENSIONAHA.108.123513
  • Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt-1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003; 111(5):649–658. DOI:10.1172/JCI17189
  • Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med. 2008; 21(1):9–23. DOI:10.1080/14767050701830480
  • Clayton PE, Cianfarani S, Czernichow P, et al. Management of the child born small for gestational age through to adulthood: a consensus statement of the international societies of pediatric endocrinology and the growth hormone research society. J Clin Endocrinol Metab. 2007; 92(3):804–810. DOI:10.1210/jc.2006-2017
  • Saenger P, Czernichow P, Hughes I, et al. Small for gestational age: short stature and beyond. Endocr Rev. 2007; 28(2):219–251. DOI:10.1210/er.2006-0039
  • Houk CP, Lee PA. Early diagnosis and treatment referral of children born small for gestational age without catch-up growth are critical for optimal growth outcomes. Int J Pediatr Endocrinol. 2012; 2012(1):11.
  • Karlberg J, Albertsson-Wikland K. Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res. 1995; 38(5):733–739.
  • Itabashi K, Mishina J, Tada H, et al. Longitudinal follow-up of height up to five years of age in infants born preterm small for gestational age; comparison to full-term small for gestational age infants. Early Hum Dev. 2007; 83(5):327–333. DOI:10.1016/j.earlhumdev.2006.07.002
  • Watanabe K, Matsubara K, Nakamoto O, et al. Outline of the new definition and classification of “hypertensive disorders of pregnancy (HDP)”; a revised JSSHP statement of 2005. Hypertens Res Pregnancy. 2018; 6(2):33–37. DOI:10.14390/jsshp.HRP2018-014
  • Fujita K, Nagasaka M, Iwatani S, et al. Prevalence of small for gestational age (SGA) and short stature in children born SGA who qualify for growth hormone treatment at 3 years of age: population-based study. Pediatr Int. 2016; 58(5):372–376. DOI:10.1111/ped.12859
  • Hokken-Koelega AC, De Ridder MA, Lemmen RJ, et al. Children born small for gestational age: do they catch up? Pediatr Res. 1995; 38(2):267–271. DOI:10.1203/00006450-199508000-00022
  • Matsumoto M, Nagano N, Awano H, et al. Incidence and neonatal risk factors of short stature and growth hormone treatment in Japanese preterm infants born small for gestational age. Sci Rep. 2019; 9(1):12238. DOI:10.1038/s41598-019-48785-y
  • Engström E, Niklasson A, Wikland KA, et al. The role of maternal factors, postnatal nutrition, weight gain, and gender in regulation of serum IGF-I among preterm infants. Pediatr Res. 2005; 57(4):605–610. DOI:10.1203/01.PDR.0000155950.67503.BC
  • Hansen-Pupp I, Löfqvist C, Polberger S, et al. Influence of insulin-like growth factor I and nutrition during phases of postnatal growth in very preterm infants. Pediatr Res. 2011; 69(5 Part 1):448–453. DOI:10.1203/PDR.0b013e3182115000
  • Cutfield WS, Regan FA, Jackson WE, et al. The endocrine consequences for very low birth weight premature infants. Growth Horm IGF Res. 2004; 14:S130–135.
  • Barker DJ, Huppert FA, Baylis N. The developmental origins of well–being. Philos Trans R Soc Lond B Biol Sci. 2004; 359(1449):1359–1366.
  • Lawn JE, Blencowe H, Oza S, et al. Every newborn: progress, priorities, and potential beyond survival. Lancet. 2014; 384(9938):189–205. DOI:10.1016/S0140-6736(14)60496-7
  • Wiedmeier JE, Joss-Moore LA, Lane RH, et al. Early postnatal nutrition and programming of the preterm neonate. Nutr Rev. 2011; 69(2):76–82. DOI:10.1111/j.1753-4887.2010.00370.x
  • Zeegers B, Offerhaus P, Peters L, et al. Impact of maternal height on birthweight classification in singleton births at term: a cohort study in the Netherlands. J Matern Fetal Neonatal Med. 2020; 35(16):1–8. DOI:10.1080/14767058.2020.1814246
  • Voigt M, Rochow N, Jährig K, et al. Dependence of neonatal small and large for gestational age rates on maternal height and weight – an analysis of the German perinatal survey. J Perinat Med. 2010; 38(4):425–430. DOI:10.1515/jpm.2010.059
  • Zhang X, Mumford SL, Cnattingius S, et al. Reduced birthweight in short or primiparous mothers: physiological or pathological? BJOG. 2010; 117(10):1248–1254. DOI:10.1111/j.1471-0528.2010.02642.x
  • Roberts G, Cheong JL. Long-term growth and general health for the tiniest or most immature infants. Semin Fetal Neonatal Med. 2014; 19(2):118–124.
  • Sohlberg S, Stephansson O, Cnattingius S, et al. Maternal body mass index, height, and risks of preeclampsia. Am J Hypertens. 2012; 25(1):120–125. DOI:10.1038/ajh.2011.175
  • Clark RH, Thomas P, Peabody J. Extrauterine growth restriction remains a serious problem in prematurely born neonates. Pediatrics. 2003; 111(5):986–990.
  • Mitsui T, Masuyama H, Eguchi T, et al. Sex differences in early growth during the first three years of life in offspring from mothers with pregnancy-induced hypertension. Pregnancy Hypertens. 2016; 6(4):361–366. DOI:10.1016/j.preghy.2016.08.238
  • Vatten LJ, Romundstad PR, Holmen TL, et al. Intrauterine exposure to preeclampsia and adolescent blood pressure, body size, and age at menarche in female offspring. Obstet Gynecol. 2003; 101(3):529–533. DOI:10.1097/00006250-200303000-00019
  • Ogland B, Vatten LJ, Romundstad PR, et al. Pubertal anthropometry in sons and daughters of women with preeclamptic or normotensive pregnancies. Arch Dis Child. 2009; 94(11):855–859. DOI:10.1136/adc.2008.150870